| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/01/2007 | US7211389 Method for producing immunoglobulins containing protection proteins and their use |
| 05/01/2007 | US7211257 Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibody |
| 05/01/2007 | US7211256 Administering to mammal polyclonal or monoclonal antibody, wherein polyclonal or monoclonal antibody recognizes an epitope of a protein of 48,000 daltons determined by immunoblot, wherein protein is a surface protein of a merozoite of Plasmodium falciparum |
| 05/01/2007 | US7211255 Contacting male ejaculate, prior to contact with a female egg, with an effective anti-fertility amount of a pharmaceutical composition, which comprises an antibody that binds a surface exposed epitope of SP22, and a pharmaceutically acceptable carrier |
| 05/01/2007 | US7211252 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 05/01/2007 | US7211251 Antibodies to transferrin receptor-like proteins |
| 05/01/2007 | CA2391384C Bt toxin receptors from lepidopteran insects and methods of use |
| 05/01/2007 | CA2191440C Treatment and prevention of helicobacter infection |
| 05/01/2007 | CA2086832C Hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines |
| 05/01/2007 | CA2076557C Process for the purification of factor xiii, monoclonal antibodies against factor xiiia, the preparation and use thereof |
| 04/26/2007 | WO2007048127A2 Fc labeling for immunostaining and immunotargeting |
| 04/26/2007 | WO2007048077A2 Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use |
| 04/26/2007 | WO2007048022A2 Antibody-polypeptide fusion proteins and methods for producing and using same |
| 04/26/2007 | WO2007047609A2 INHIBITION OF PLACENTA GROWTH FACTOR (PlGF) MEDICATED METASTASIS AND/OR ANGIOGENESIS |
| 04/26/2007 | WO2007047578A2 Cell display of antibody libraries |
| 04/26/2007 | WO2007047291A2 Anti-glypican-3 antibody |
| 04/26/2007 | WO2007047189A2 Targeted biocides |
| 04/26/2007 | WO2007047112A2 Anti-myostatin antibodies |
| 04/26/2007 | WO2007046893A2 Methods for generating bioactive assemblies and uses thereof |
| 04/26/2007 | WO2007046439A1 Transgenic silkworm capable of producing antibody and method for production thereof |
| 04/26/2007 | WO2007045927A2 Therapeutic agent |
| 04/26/2007 | WO2007045911A1 Integral membrane protein |
| 04/26/2007 | WO2007045661A1 Detection or quantification of aggrecan and its fragments |
| 04/26/2007 | WO2007045477A2 Human antibodies against il-13 and therapeutic uses |
| 04/26/2007 | WO2007045476A2 Organic compounds |
| 04/26/2007 | WO2007012944A3 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 04/26/2007 | WO2007008221A3 DETECTION OF PHOSPHORYLATED eIF2α AS A DIAGNOSTIC TEST FOR EFFICIENCY AND SENSITVITY OF TRANSLATION INITIATION INHIBITORS IN THE TREATMENT OF CANCER AND OTHE R PROLIFERATIVE DISEASES |
| 04/26/2007 | WO2007000671A3 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 04/26/2007 | WO2006137931A3 Human monoclonal antibodies against hendra and nipah viruses |
| 04/26/2007 | WO2006121422A8 Antibodies against clostridium difficile toxins and uses thereof |
| 04/26/2007 | WO2006114700A3 Method of producing human igg antibodies with enhanced effector functions |
| 04/26/2007 | WO2006113880A3 Intact igfbp-3 as a colon cancer risk factor in patients with inflammatory bowel disease |
| 04/26/2007 | WO2006109191A3 Human anti-interferon gamma antibodies and methods of use thereof |
| 04/26/2007 | WO2006104615A3 Influenza nucleic acids, polypeptides, and uses thereof |
| 04/26/2007 | WO2006093923A3 Treatment of bone disorders |
| 04/26/2007 | WO2006089678A3 Antibodies and peptides binding to hiv tat, and uses thereof |
| 04/26/2007 | WO2006086208A3 5-fluoro-uracil immunoassay |
| 04/26/2007 | WO2006074451A9 Targeted chimeric molecules for cancer therapy |
| 04/26/2007 | WO2006071896A3 Epitope-based sars vaccine |
| 04/26/2007 | WO2006060188A3 Anti-tenascin monoclonal antibody immunoassays and diagnostic kits |
| 04/26/2007 | US20070093651 Ligand |
| 04/26/2007 | US20070093441 useful to efficiently induce self-specific immune responses; comprising a virus-like particle and at least one protein, or peptide of IL-5, IL-13 and/or eotaxin |
| 04/26/2007 | US20070093434 Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 04/26/2007 | US20070093419 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 04/26/2007 | US20070093418 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 04/26/2007 | US20070092941 PRO1298 polypeptides |
| 04/26/2007 | US20070092940 Cysteine engineered antibodies and conjugates |
| 04/26/2007 | US20070092938 Diagnostics for sars virus |
| 04/26/2007 | US20070092922 Taxol immunoassay |
| 04/26/2007 | US20070092921 Measuring hemoglobin and albumin, which indicate presence of gastric and/or colonic ulcers or bleeding |
| 04/26/2007 | US20070092920 Serum Prolactin Binding Protein in Epithelial Carcinoma |
| 04/26/2007 | US20070092918 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer |
| 04/26/2007 | US20070092916 Using concentration of iron regulating polypeptide to detect blood disorders; immunoassay |
| 04/26/2007 | US20070092910 Alcohol dehydrogenase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases |
| 04/26/2007 | US20070092887 method of repeated cycles of mutagenesis, shuffling and selection which allow for the directed molecular evolution in vitro or in vivo of proteins; generating and selecting or screening for desired nucleic acid fragments encoding mutant proteins |
| 04/26/2007 | US20070092866 Avian adenoassociated virus and uses thereof |
| 04/26/2007 | US20070092530 Antibodies as T cell receptor mimics, methods of production and uses thereof |
| 04/26/2007 | US20070092529 Using gene encoding transmembrane ptorein |
| 04/26/2007 | US20070092525 Polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual |
| 04/26/2007 | US20070092523 Combination Therapy Of Respiratory Diseases Using Antibodies |
| 04/26/2007 | US20070092521 producing a glycosylated monoclonal antibody or Fc fusion protein by culturing the cell in the presence of kifunensine ; for targeted killing of cells in a mammal, including therapeutic methods of treating cancers, autoimmune diseases and other diseases |
| 04/26/2007 | US20070092520 Humanized Anti-CMET Antagonists |
| 04/26/2007 | US20070092518 Anti-TNFalpha antibodies and methods of use |
| 04/26/2007 | US20070092517 Truncated memapsin 2 compositions and treatments |
| 04/26/2007 | US20070092516 Antibody preparation |
| 04/26/2007 | US20070092515 Methods of treating chronic pain using compositions that specifically bind cd11d (alpha-d) integrin |
| 04/26/2007 | US20070092514 Novel secreted immunomodulatory proteins and uses thereof |
| 04/26/2007 | US20070092513 Antiproliferative agents; anticancer agents; controlling excessive proliferation or migration of smooth muscle cells by treating said smooth muscle cells with an effective amount of an antagonist of a native ErbB4 receptor |
| 04/26/2007 | US20070092511 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 04/26/2007 | US20070092507 Anti-FcRn antibodies for treatment of auto/allo immune conditions |
| 04/26/2007 | US20070092506 Use of rapamycin and agents that inhibit B7 activity in immunomodulation |
| 04/26/2007 | US20070092505 Production of humanized antibodies in transgenic animals |
| 04/26/2007 | US20070092504 Use of agents that modulate the interaction between PD-1 and its ligands in the downmodulation of immune responses |
| 04/26/2007 | US20070092443 Antibodies That Recognize Hyperproliferative Cells and Methods of Making and Using Same |
| 04/26/2007 | CA2630415A1 Fc labeling for immunostaining and immunotargeting |
| 04/26/2007 | CA2626556A1 Antibody-based therapeutics with enhanced adcc activity |
| 04/26/2007 | CA2626542A1 Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and use |
| 04/26/2007 | CA2626013A1 Methods for generating monovalent igg |
| 04/26/2007 | CA2625992A1 Inhibition of placenta growth factor (p1gf) mediated metastasis and/or angiogenesis |
| 04/26/2007 | CA2625664A1 Human antibodies against il13 and therapeutic uses |
| 04/26/2007 | CA2625619A1 Cell display of antibody libraries |
| 04/26/2007 | CA2625580A1 Targeted biocides |
| 04/26/2007 | CA2624931A1 Therapeutic agent |
| 04/26/2007 | CA2624894A1 Anti-glypican-3 antibody |
| 04/26/2007 | CA2607056A1 Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 04/25/2007 | EP1777524A1 Chimera of human IgE receptor alpha-chain and avian constant immunoglobulin domains for the determination of serum IgE |
| 04/25/2007 | EP1777235A1 Compositions and methods for treating inflammatory disorders |
| 04/25/2007 | EP1777234A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 04/25/2007 | EP1777233A2 Gonococcal proteins and nucleic acids |
| 04/25/2007 | EP1776387A1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 04/25/2007 | EP1776386A1 Anti-ghrelin antibodies |
| 04/25/2007 | EP1776385A1 Immunoglobulins comprising predominantly a glcnac2man3glcnac2 glycoform |
| 04/25/2007 | EP1776384A2 Variant fc regions |
| 04/25/2007 | EP1776383A2 Binding molecules |
| 04/25/2007 | EP1776142A1 Il-17 antagonistic antibodies |
| 04/25/2007 | EP1776132A2 Natriuretic compounds, conjugates, and uses thereof |
| 04/25/2007 | EP1476463B1 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen |
| 04/25/2007 | EP1430133B1 A soluble toll-like receptor |
| 04/25/2007 | EP1425042B1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 04/25/2007 | EP1320542B1 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |